Regulation: Putting a price on life
Government agencies have to weigh the value of lives saved against the cost of regulation.
“What is the value of a human life?” said Binyamin Appelbaum in The New York Times. For government agencies, that question isn’t theoretical. To judge the efficacy of the rules they impose on industry, agencies have to weigh the value of lives saved against the cost of regulation. Under the Obama administration, “one agency after another has ratcheted up the price of life, justifying tougher and more costly” regulations. Last year the administration demanded that automakers meet a more stringent and expensive standard for car roofs in order to save an estimated 135 people from dying annually in rollovers. By simply raising the value of each life saved—from $3.5 million under the Bush administration to $6.1 million today—the Department of Transportation made the aggregate value of the lives preserved higher than what it would cost industry to strengthen the roofs. A similar pattern throughout the government has resulted in “protests from businesses and praise from unions, environmentalists, and consumer groups.”
Yet not all lives—or deaths—are equal in this jerry-rigged system, said James Heiser in TheNew​​American.com. While the transportation department values a life at $6.1 million, the Environmental Protection Agency pegs it at $9.1 million. The EPA has even said it might apply a “cancer differential,” arguing, in effect, that slow death by cancer is 50 percent worse than death by other means. Regulations “based on something as vague as a perceived sense of more or less desirable forms of death” show just how arbitrary the system is. And how “dangerous,” said David Ropeik in The Washington Post. The EPA is responding to the fact that most of us find cancer “scarier” than, say, heart disease. But heart disease kills 50,000 more of us per year. So while endorsing our “misperceptions,” the EPA is failing to do its job of properly assessing risk.
Regulators are only human, said Felix Salmon in Reuters.com, and their task is to make just these sorts of difficult distinctions. “Dying of cancer is a particularly gruesome—and expensive—way to go.” (Likewise, deaths caused by terrorism can cost billions; just look at what we’ve spent in the wake of 9/11.) So “a little bit of fuzziness” in these calculations seems entirely appropriate. You can’t simply ignore human impulses, or political ones, in a place like Washington. Given the even less rigorous alternatives, we should count ourselves lucky that bureaucrats are trying to base “these decisions on some kind of numerical argument” at all.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Trinidadian doubles recipe
The Week Recommends 'Dangerously addictive', this traditional Caribbean street food is the height of finger-licking goodness
By Rebekah Evans, The Week UK
-
Labour and the so-called 'banter ban'
Talking Point Critics are claiming that a clause in the new Employment Rights Bill will spell the end of free-flowing pub conversation
By Richard Windsor, The Week UK
-
Andor series two: a 'perfect' Star Wars show
The Week Recommends Second instalment of Tony Gilroy's 'compelling' spin-off is a triumph
By Irenie Forshaw, The Week UK
-
The JFK files: the truth at last?
In The Spotlight More than 64,000 previously classified documents relating the 1963 assassination of John F. Kennedy have been released by the Trump administration
By The Week Staff
-
'Seriously, not literally': how should the world take Donald Trump?
Today's big question White House rhetoric and reality look likely to become increasingly blurred
By Sorcha Bradley, The Week UK
-
Will Trump's 'madman' strategy pay off?
Today's Big Question Incoming US president likes to seem unpredictable but, this time round, world leaders could be wise to his playbook
By Sorcha Bradley, The Week UK
-
Democrats vs. Republicans: who are the billionaires backing?
The Explainer Younger tech titans join 'boys' club throwing money and support' behind President Trump, while older plutocrats quietly rebuke new administration
By Harriet Marsden, The Week UK
-
US election: where things stand with one week to go
The Explainer Harris' lead in the polls has been narrowing in Trump's favour, but her campaign remains 'cautiously optimistic'
By Harriet Marsden, The Week UK
-
Is Trump okay?
Today's Big Question Former president's mental fitness and alleged cognitive decline firmly back in the spotlight after 'bizarre' town hall event
By Harriet Marsden, The Week UK
-
The life and times of Kamala Harris
The Explainer The vice-president is narrowly leading the race to become the next US president. How did she get to where she is now?
By The Week UK
-
Will 'weirdly civil' VP debate move dial in US election?
Today's Big Question 'Diametrically opposed' candidates showed 'a lot of commonality' on some issues, but offered competing visions for America's future and democracy
By Harriet Marsden, The Week UK